Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis

NCT00893880 is registered in ClinicalTrials.gov with Nitric BioTherapeutics, Inc as lead sponsor.

NCT NCT00893880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00893880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis
Lead sponsor
Nitric BioTherapeutics, Inc
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
May 31, 2010
Enrollment
92 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tinea pedis